PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.\', \'Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: sronteddu@uams.edu.\', \'Department of Neurology, University of Maryland Baltimore Washington Medical Center, Glen Burnie, MD, USA.\', \'Department of Medicine, University of Arkansas for Medical Sciences /Baptist Health Program, North Little Rock, AR, USA.\', \'Department of Neurology, Yale University School of Medicine, New Haven, CT, USA. Electronic address: richard.nowak@yale.edu.\', \'Department of Neurology, Yale University School of Medicine, New Haven, CT, USA. Electronic address: bhaskar.roy@yale.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-510X(20)30566-910.1016/j.jns.2020.117230
?:hasPublicationType
?:journal
  • Journal of the neurological sciences
is ?:pmid of
?:pmid
?:pmid
  • 33256952
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.002
?:rankingScore_hIndex
  • 120
?:title
  • Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all